MPO and inflammatory bowel disease: When BSB was administered 3 days before IBD induction, MPO levels were significantly (p < 0.01, n = 6) decreased from 61,739.57 ± 16,904.11 in the untreated IBD group to 22,289.12 ± 4611.25 ng/mL of protein and from 32,552.37 ± 7002.41 to 5241.94 ± 1135.46 ng/mg of protein on days 2 and 4, respectively.